Savara News - SVRA

Company Name	Stock Ticker Symbol	Market	Type
Savara Inc	SVRA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.06	-1.25%	4.73	13:23:52

Open Price	Low Price	High Price	Close Price	Prev Close
4.75	4.6303	4.82		4.79

more quote information »

Recent News

Date	Time	Source	Heading
4/08/2024	08:05	BW	Savara to Present New Data on Autoimmune Pulmonary Alveolar..
3/22/2024	16:05	BW	Savara Announces New Employment Inducement Grant
3/07/2024	16:26	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
3/07/2024	16:05	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/07/2024	16:05	BW	Savara Reports Fourth Quarter/Year-End 2023 Financial..
3/06/2024	16:05	BW	Savara to Present at the Barclays 26th Annual Global..
2/16/2024	08:31	EDGAR2	Form 8-K - Current report
2/14/2024	20:35	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	16:15	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	21:00	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/07/2024	08:01	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/02/2024	08:05	BW	Savara Announces New Employment Inducement Grant
2/01/2024	15:50	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/31/2024	14:08	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
1/31/2024	08:05	BW	Savara to Present at Two Upcoming Healthcare Conferences
1/25/2024	16:06	EDGAR2	Form 8-K - Current report
1/05/2024	08:00	EDGAR2	Form 8-K - Current report
12/29/2023	16:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/29/2023	16:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/29/2023	16:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/28/2023	16:29	EDGAR2	Form 144 - Report of proposed sale of securities
12/28/2023	16:15	EDGAR2	Form 144 - Report of proposed sale of securities
12/28/2023	16:10	EDGAR2	Form 144 - Report of proposed sale of securities
12/21/2023	08:05	BW	Savara Introduces aPAP ClearPath™, a GM-CSF Autoantibody..
12/20/2023	08:05	BW	Savara Added to the NASDAQ Biotechnology Index
12/18/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	18:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	17:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	17:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	17:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	17:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	17:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	17:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	17:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	17:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	16:05	BW	Savara Announces New Employment Inducement Grant
12/12/2023	18:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/12/2023	18:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/21/2023	08:05	BW	Savara to Present at the Piper Sandler 35th Annual..
11/09/2023	16:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	16:05	BW	Savara Reports Third Quarter Financial Results and Provides..
11/08/2023	16:05	BW	Savara to Present at the Jefferies London Healthcare..
10/06/2023	16:05	BW	Savara Announces New Employment Inducement Grant
9/05/2023	16:05	BW	Savara to Present at the H.C. Wainwright 25th Annual Global..
8/10/2023	16:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	16:05	BW	Savara Reports Second Quarter Financial Results and Provides..
8/04/2023	16:05	BW	Savara Announces New Employment Inducement Grant
7/26/2023	16:57	EDGAR2	Form SC 13D/A - General statement of acquisition of..
7/25/2023	16:17	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
7/19/2023	19:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..